PHARMACY

FDA gives tentative nod for Perrigo’s generic Finacea

Finacea foam had a market value of roughly $62 million for the 12 months ended January 2019.
AAM names Karin Hessler assistant general counsel

Karin Hessler will focus on Hatch-Waxman, biosimilar and pharmaceutical patent issues.
Novo Nordisk, Teva ink generic Victoza settlement

Teva is licensed to launch a generic version of Victoza as of Dec. 22, 2023 as the result of its settlement with Novo Nordisk, which manufactures the branded version of the drug.
FDA approves pediatric indication for Allergan’s Avycaz

This is the first Food and Drug Administration approval of a pediatric indication for complicated intra-abdominal infections and complicated urinary tract infections in more than a decade, Allergan said.
NACDS praises 7-day prescription bill to mitigate opioid abuse

The legislation would help prevent addiction and abuse, and help prevent opioids from falling into the wrong hands.
West Virginia Medicaid saves $54.4M with prescription drug carve out

The prescription drug carve out resulted in $122 million in pharmacy dispensing fees to West Virginia pharmacies.
Zydus Cadila gets FDA clearance for generic Diovan

Zydus Cadila's generic Diovan tablets come in several dosage strengths.
NACDS praises Arkansas e-prescribing law preventing opioid abuse

The bill, which requires electronic prescribing of Schedules I through VI controlled substances, goes into effect Jan. 1, 2021.